microRNA-17~92 is a powerful cancer driver and a therapeutic target

Cell Cycle. 2014;13(4):495-6. doi: 10.4161/cc.27784. Epub 2014 Jan 13.

Authors

Hyun Yong Jin¹, Maoyi Lai², Changchun Xiao²

Affiliations

¹ Department of Immunology and Microbial Science; The Scripps Research Institute; La Jolla, CA USA; Kellogg School of Science and Technology; The Scripps Research Institute; La Jolla, CA USA.
² Department of Immunology and Microbial Science; The Scripps Research Institute; La Jolla, CA USA.

No abstract available

Keywords: MicroRNA; NFκB; PI3K; cancer; lymphoma; miR-17~92; therapeutics.

Publication types

Editorial
Comment

MeSH terms

Animals
Gene Expression Regulation, Neoplastic*
Humans
Lymphoma / genetics*
MicroRNAs / physiology*

Substances

MicroRNAs

Grants and funding